Centric Health Resources supports third annual Rare Disease Day FDA committee recommends approval of Xifaxan Inhaled CF antibiotic receives FDA approval Combined HIV drug therapy may cause heart rhythm issues Decision Resources projects Crohn's disease market surge FDA approves Parkinson's disease treatment FDA approved more than 50 cancer drugs in two years, study says Novartis' Tasigna receives priority review from FDA Rituxan gets nod of approval from FDA Drug makers sign agreement to develop rheumatoid arthritis drug First Previous 210 211 212 213 214 Next Last
